San Francisco, CA, United States of America

Andrew Pincetic

USPTO Granted Patents = 8 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
8 patents (USPTO):Explore Patents

Title: Spotlight on Inventor Andrew Pincetic: Driving Innovation in San Francisco

Introduction:

Andrew Pincetic, a prolific inventor based in San Francisco, CA, is making waves in the field of biotechnology with his groundbreaking patents and contributions to the industry. With a strong focus on antibody research, Pincetic is at the forefront of developing novel therapeutic interventions.

Latest Patents:

Pincetic's recent patents showcase his expertise in antibody technology. His patents include "Anti-SIRP-alpha antibodies and methods of use thereof," which introduces innovative anti-SIRPA antibodies for therapeutic purposes. Additionally, "Anti-TREM1 antibodies and methods of use thereof" highlights his advancements in developing antibodies targeting the TREM1 protein for medical applications.

Career Highlights:

Currently affiliated with Alector LLC, a leading biotechnology company, Pincetic plays a pivotal role in driving research and development efforts. His innovative mindset and dedication to advancing the field have positioned him as a key figure in the company's success.

Collaborations:

Pincetic collaborates closely with esteemed colleagues such as Arnon Rosenthal and Seung-Joo Lee, pooling their expertise to push the boundaries of biotechnology. Together, they form a dynamic team that is instrumental in driving innovation and accelerating progress in the industry.

Conclusion:

Inventor Andrew Pincetic's remarkable journey in the realm of biotechnology exemplifies a commitment to innovation and a relentless pursuit of scientific excellence. His groundbreaking patents and collaborative efforts underscore his significant contributions to the field, marking him as a key figure in shaping the future of biotechnological advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…